NCT05325710View on ClinicalTrials.gov

Assessment of Personalized Follow-up in Prevention of Type 2 Diabetes

NARecruitingINTERVENTIONAL
Enrollment

230

Participants

Timeline

Start Date

March 20, 2022

Primary Completion Date

April 1, 2028

Study Completion Date

April 1, 2028

Conditions
Diabete Type 2
Interventions
BEHAVIORAL

Study nurse intervention

Contact everay 4 months with a dedicated study nurse

Trial Locations (1)

64200

RECRUITING

Clinique Aguiléra, Biarritz

Sponsors
All Listed Sponsors
collaborator

European Clinical Trial Experts Network

OTHER

lead

Ramsay Générale de Santé

OTHER

NCT05325710 - Assessment of Personalized Follow-up in Prevention of Type 2 Diabetes | Biotech Hunter | Biotech Hunter